Perouansky M
Department of Anesthesiology, University of Wisconsin School of Medicine, B6/319 Clinical Science Center, 600 Highland Ave., Madison, WI 53792-3272, USA.
Handb Exp Pharmacol. 2008(182):209-23. doi: 10.1007/978-3-540-74806-9_10.
Nonimmobilizing, inhalational anesthetic-like compounds are experimental agents developed as a tool to investigate the mechanism of action of general anesthetics. Clinically used for more than 150 years, general anesthesia has until now defied all attempts to formulate a theory of its mechanisms that would link, in an uninterrupted logical chain, observations on the molecular level-via effects on the cellular and network levels-to the in vivo phenomenon. Nonimmobilizers, initially termed nonanesthetics, are substances that disobey the Meyer-Overton rule. Theoretically, in appropriately designed experiments, nonanesthetics can serve as a type of Ockham's razor to separate important from irrelevant observations: processes that, at comparable concentrations, are affected to a similar degree by inhalational anesthetics and by nonanesthetics, do not contribute to anesthesia (the nonanesthetic algorithm). In practice, however, this appealing algorithm has been rather difficult to apply. On one hand, nonanesthetics are not inert on the behavioral level: they cause, inter alia, amnesia. This discovery required not only the introduction of the more precise term "nonimmobilizers," but also excluded one important component of anesthesia, i.e., amnesia, from application of the algorithm. On the other hand, compared to inhalational anesthetics, nonimmobilizers interact with relatively few molecular targets, also limiting the usefulness of the nonimmobilizer algorithm. Nevertheless, nonimmobilizers have not only yielded useful results but can, by virtue of those very properties that make them less than ideal for anesthesia research, be used as experimental tools in the neurosciences far beyond anesthetic mechanisms.
非麻醉性、吸入性麻醉样化合物是作为研究全身麻醉作用机制的工具而开发的实验性药物。全身麻醉临床应用已有150多年,但迄今为止,所有试图构建其作用机制理论的尝试均未成功,该理论应能在一个不间断的逻辑链条中,将分子水平的观察结果——通过对细胞和网络水平的影响——与体内现象联系起来。非麻醉剂最初被称为非麻醉药物,是一类不符合迈耶-奥弗顿规则的物质。从理论上讲,在经过适当设计的实验中,非麻醉药物可作为一种奥卡姆剃刀,将重要观察结果与无关观察结果区分开来:在可比浓度下,吸入性麻醉剂和非麻醉药物以相似程度影响的过程,对麻醉没有贡献(非麻醉算法)。然而,在实践中,这种颇具吸引力的算法很难应用。一方面,非麻醉药物在行为水平上并非惰性的:它们尤其会导致失忆。这一发现不仅需要引入更精确的术语“非麻醉剂”,还将麻醉的一个重要组成部分,即失忆,排除在该算法的应用范围之外。另一方面,与吸入性麻醉剂相比,非麻醉药物与相对较少的分子靶点相互作用,这也限制了非麻醉剂算法的实用性。尽管如此,非麻醉药物不仅产生了有用的结果,而且凭借那些使其不太适合麻醉研究的特性,还可作为神经科学领域远超麻醉机制的实验工具。